{
"NDC": {
"NDCCode": "33342-551-09",
"PackageDescription": "60 CAPSULE in 1 BOTTLE (33342-551-09) ",
"NDC11Code": "33342-0551-09",
"ProductNDC": "33342-551",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Nintedanib Esylate",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Nintedanib Esylate",
"DosageFormName": "CAPSULE",
"RouteName": "ORAL",
"StartMarketingDate": "20260803",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA219926",
"LabelerName": "Macleods Pharmaceuticals Limited",
"SubstanceName": "NINTEDANIB ESYLATE",
"StrengthNumber": "150",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-08-05",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260803",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}